PAG
TAK icon

Private Advisor Group’s Takeda Pharmaceutical TAK Stock Holding History

Private Advisor Group’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26,488
Closed -$491K – 2885
2026
Q1 		$491K Buy
26,488
+3,892
+17% +$68.3K ﹤0.01% 1867
2025
Q4 		$352K Buy
22,596
+1,277
+6% +$18.3K ﹤0.01% 2045
2025
Q3 		$312K Buy
+21,319
New +$317K ﹤0.01% 2063
2024
Q4 		– Sell
-12,247
Closed -$174K – 2492
2024
Q3 		$174K Buy
12,247
+520
+4% +$7.38K ﹤0.01% 2249
2024
Q2 		$152K Sell
11,727
-847
-7% -$11.2K ﹤0.01% 2189
2024
Q1 		$175K Sell
12,574
-6,037
-32% -$87.8K ﹤0.01% 2142
2023
Q4 		$266K Sell
18,611
-443
-2% -$6.29K ﹤0.01% 1859
2023
Q3 		$295K Buy
19,054
+2,254
+13% +$34.9K ﹤0.01% 1639
2023
Q2 		$259K Buy
+16,800
New +$275K ﹤0.01% 1713
2023
Q1 		– Sell
-10,629
Closed -$166 – 2036
2022
Q4 		$166 Buy
10,629
+41
+0.4% +$573 ﹤0.01% 1537
2022
Q3 		$137K Sell
10,588
-159,479
-94% -$2.22M ﹤0.01% 1738
2022
Q2 		$2.39M Buy
170,067
+35,385
+26% +$505K 0.02% 663
2022
Q1 		$1.93M Buy
134,682
+42,439
+46% +$623K 0.01% 816
2021
Q4 		$1.26M Sell
92,243
-28,604
-24% -$401K 0.01% 1007
2021
Q3 		$1.98M Buy
120,847
+74,973
+163% +$1.26M 0.01% 886
2021
Q2 		$772K Buy
45,874
+11,745
+34% +$200K 0.01% 1191
2021
Q1 		$623K Buy
34,129
+11,576
+51% +$208K 0.01% 1198
2020
Q4 		$410K Buy
+22,553
New +$396K ﹤0.01% 1321
2020
Q3 		– Sell
-4,790
Closed -$86K – 3207
2020
Q2 		$86K Buy
+4,790
New +$86K ﹤0.01% 1801

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Private Advisor Group's TAK Position: Q2 2026 in Review

Private Advisor Group sold out of Takeda Pharmaceutical (TAK) in Q2 2026, closing a stake of 26,488 shares — an estimated $491K sold.

Private Advisor Group first reported a position in TAK in Q2 2020 and held it in 19 quarters. The position peaked at $2.39M in Q2 2022. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Private Advisor Group reported no remaining Takeda Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Private Advisor Group sold 26,488 Takeda Pharmaceutical shares in Q2 2026, an estimated $491K.
  • Private Advisor Group first reported a position in Takeda Pharmaceutical in Q2 2020 and held it in 19 quarters.
  • Private Advisor Group's Takeda Pharmaceutical position peaked at $2.39M in Q2 2022.
  • 378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.